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ABSTRACT 
Background 
Depression is the leading global cause of disability and often begins in adolescence. The 
genetic architecture and treatment response profiles for adults and adolescents differ even 
though identical criteria are used to diagnose depression across different age groups. There 
is no clear consensus on how these groups differ in their symptom profiles.  
Methods 
Using data from a two-generation family study, we compared the presentation of DSM-IV 
depressive symptoms in adolescents and adults with MDD (Major Depressive Disorder).  We 
also compared DSM-IV depressive symptom counts using latent class analysis.  
Results 
Vegetative symptoms (appetite and weight change, loss of energy and insomnia) were more 
common in adolescent MDD than adult MDD.  Anhedonia/loss of interest and concentration 
problems were more common in adults with MDD.  When using latent class analysis to look 
at depressive symptoms, a vegetative symptom profile was also seen in adolescent 
depression only.   
Limitations 
Adults and adolescents were recruited in different ways.  Adolescent cases were more likely 
to be first-onset while adult cases were recurrences. It was not possible to examine how 
recurrence affected adolescent depression symptom profiles.   
Conclusion 
Differences in how depression presents in adolescents and adults may be consistent with 
different pathophysiological mechanisms.  For adolescents, we found that 
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vegetative/physical disturbances were common (loss of energy, changes in weight, appetite 
and sleep changes).  For adults, anhedonia/loss of interest and concentration difficulties 
were more common.   
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Introduction 
Major depressive disorder (MDD) affects 350 million people worldwide and is the single 
largest contributor to years lived with disability (Vos et al., 2012).  It is the top cause of 
disability in adolescents and young adults.  During adolescence, the incidence of depressive 
symptoms and MDD increases sharply (Thapar et al., 2012).  Adolescence is a risk period 
for the onset of depression with high recurrence rates and poor functional outcomes (Dunn 
and Goodyer, 2006).  
 
Identical diagnostic criteria are used to define major depressive disorder in adults and in 
children/adolescents.  The one exception to this is that DSM-IV and 5 (APA, 2000, 2013) 
allow irritable rather than depressed mood as a core diagnostic mood symptom for 
children/adolescents. The use of the same diagnostic criteria in adults, children and 
adolescents implies that the presentation of the disorder is age-independent.  Indeed, there 
is evidence to support the suggestion that, in terms of risk factors, neural correlates and 
continuity over time, adolescent-onset MDD can be viewed as an early-onset form of the 
adult disorder (Maughan, Collishaw & Stringaris, 2013; Rutter, Kim-Cohen & Maughan, 
2006; Thapar et al., 2012). Nevertheless, there are important aetiological differences 
between adolescent and adult disorder in terms of treatment response and genetic 
architecture.  The evidence for the effectiveness of antidepressants in treating adolescent 
depression is sparser than that for adult depression.  In particular, selective serotonin 
reuptake inhibitors (SSRIs) and tricylic antidepressants show smaller effect sizes in treating 
depression in adolescents compared to adults (Hazell et al., 1995; Hazell & Mirzaie, 2013; 
Locher et al., 2017; Thapar et al., 2012).  This may be partly due to a higher placebo 
response for depression in young people (Janiaud et al., 2017).  Third generation 
antidepressants such as SNRIs and mirtazapine have not shown to be significantly better 
than placebo (Thapar et al., 2012; Locher et al., 2017).  Interestingly, the effect size for 
Cognitive Behavioural Therapy also appears to be lower for adolescent than adult 
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depression (Weisz et al., 2017).  Studies also suggest that there is genetic heterogeneity of 
depression according to age of onset such that a relatively earlier age of onset is more 
strongly associated with alleles that confer risk for bipolar disorder and schizophrenia 
compared to later onset depression (Power et al., 2017; Verduijn et al., 2017).  Similarly, 
evidence from twin studies suggests genetic differences between paediatric and adult 
depression (Lau and Eley, 2010; Rice, 2010; Rice et al., 2002). Collectively, evidence 
suggests aetiological differences between adolescent and adult depression.   
 
Clinical descriptions of major depressive disorder (MDD) in adolescents also suggest 
possible differences in the presentation compared to that in adults.  In particular that specific 
vegetative symptoms including appetite and weight disturbance, fatigue and insomnia may 
be particularly common in clinically depressed children and adolescents (Goodyer and 
Cooper, 1993; Nardi et al., 2013; Roberts et al., 1995; Ryan et al., 1987).  Interestingly, 
hypersomnia appears less common in young people (Kovacs, 1996).  Somatic symptoms 
which refer to unexplained physical complaints such as musculoskeletal pain or headaches 
have also been reported as being particularly common in clinically depressed children and 
adolescents (McCauley et al., 1991; Nardi et al., 2013; Ryan et al., 1987).  Probably the 
largest study of symptom profiles in adolescent depression involved using item response 
theory to assess the relationship of depressive symptoms to the underlying dimension of 
depression (Cole et al., 2011).  That study identified concentration problems, feelings of 
worthlessness/guilt and sleep disturbance as present at low levels of depression severity, 
while psychomotor agitation/retardation, weight and appetite change and suicidal ideation or 
attempts were present only at high levels of depression severity (Cole et al., 2011).  
Nonetheless, interpretation of these potential differences in the presentation of MDD 
between adolescents and adults is obscured due to between-study inconsistencies in how 
symptoms are assessed and the lack of studies that directly compare adult and adolescent 
MDD symptoms using similar assessment and recruitment methods.  Indeed, it has been 
highlighted that comparisons have been unsystematic (Kovacs, 1996).  There is a need for 
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studies that directly compare the presentation of depressive symptomatology in adolescents 
to adults in samples using comparable recruitment and assessment methods.  A 
consideration of depressive symptoms would also be informative given that these are 
functionally impairing, frequently occur in between ‘full-blown’ episodes of clinical depression 
and predict subsequent major depressive episodes both in adolescents and adults (Angold 
et al., 1999; Johnson et al., 1992; Judd et al., 1998; Pickles et al., 2001).   
 
In a large study of depression where adults with a history of recurrent MDD and their 
adolescent offspring were rigorously assessed using similar clinical diagnostic interviews on 
three occasions, we examined the following research questions:   
1. Are there differences in the symptomology exhibited by adults and adolescents with a 
diagnosis of major depressive disorder? 
2. Are there differences in the profiles of depressive symptoms exhibited by adults and 
adolescents? 
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Methods 
This study utilised data from the ‘Early Prediction of Adolescent Depression’ (EPAD) study 
which includes 335 adults with recurrent Major Depressive Disorder (MDD) and their 
adolescent offspring.  All adults had a history of two or more major depressive episodes, 
were recruited mainly from primary care and had a biological child living at home aged 9-17 
years at baseline (Mars et al., 2012).  The sampling strategy involved recruiting adults with 
recurrent MDD who at baseline were living with a child within the study age range (9 to 17 
years) to whom they were biologically related.  Prior to participation, adults were screened 
by the research team over the telephone to ensure their family fulfilled the inclusion criteria. 
These were: recurrent unipolar depression in the parent (at least 2 episodes; later confirmed 
by diagnostic interview) but the parent need not have been experiencing a depressive 
episode at the time of recruitment. Living with a biological child in the age range of the study.  
Parents with a psychotic or bipolar diagnosis and those who met DSM-IV criteria for 
mania/hypomania at the time of interview were excluded from the study. Families were also 
excluded if the participating child had moderate–severe intellectual disability (IQ <50). There 
were no diagnostic exclusion criteria for the children at study entry.  Clinical interviews of the 
parent’s and the adolescent’s current mental state were undertaken on three occasions at 
approximately annual intervals.   
 
At each adult assessment, diagnosis of DSM-IV MDD during the preceding month was 
based on a semi-structured interview, the Schedules for Clinical Assessment in 
Neuropsychiatry (Wing et al., 1990).  All interviewers were trained in the use of the SCAN 
and diagnoses were discussed at clinical consensus meetings led by a consultant 
psychiatrist (DJS).  Adults reported on family history of depression and other major 
psychiatric disorders in first and second degree relatives.  
 
In the adolescents, depressive symptoms were assessed with the Child and Adolescent 
Psychiatric Assessment (CAPA) (Angold and Costello, 2000) which is a semi-structured 
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diagnostic interview that derives psychiatric symptoms and diagnoses during the preceding 3 
months. The parent and child assessments were completed independently by trained, 
supervised interviewers. Diagnosed and sub-threshold cases were reviewed by two 
experienced child and adolescent psychiatrists (AT and RP).  MDD in adults and 
adolescents was defined as the presence of at least 5 depressive symptoms, including one 
of the core symptoms of low mood or irritability or loss of interest/pleasure plus depression-
related impairment.  Symptoms were derived from the respective interviews for adolescents 
and adults.  In general, symptoms were tapped by similar questions with slight differences in 
language to ensure the interviews were age appropriate.  For instance, in the CAPA, 
depressed mood was prompted by asking about “feeling unhappy, miserable, blue, low 
spirited, being down in the dumps or dejected” while in the SCAN depressed mood was 
prompted by asking about “ feeling low in spirits, describing mood as sad, downcast, gloomy, 
despairing or deeply depressed.”  In terms of thresholds and durations for symptoms to be 
endorsed, these were broadly similar across the CAPA and SCAN.  For example, for 
insomnia to be endorsed a reduction in sleep of over 1 hour was required for both interviews.  
Slight differences in questions and thresholds were observed for loss of energy (where the 
CAPA asked about tiredness, fatigability and subjective loss of energy while the SCAN 
asked about loss of energy and for concentration where the CAPA asked about inefficient 
thinking and indecisiveness and the SCAN asked about loss of concentration and 
subjectively inefficient thinking).  Otherwise, items were very similar across the interviews for 
young person and adult. 
 
The primary outcome variable was the cumulative prevalence of MDD defined as the 
presence of an episode of MDD at any of the three assessment points over the course of the 
study.  Where individuals met criteria for current MDD at more than one of the three 
assessments, the first episode was selected.  109 (32.5%) adults and 37 (11%) adolescents 
met DSM-IV diagnostic criteria for current MDD on at least one occasion over the course of 
the study.  The secondary outcome variable was DSM-IV depressive symptom count.  
9 
 
Analyses of depressive symptoms included participants with at least one DSM-IV depressive 
symptom (233 adults (69.9%) and 236 adolescents (70.4%)) as this was required for latent 
class analysis.   
 
Statistical analysis  
We first examined rates of symptom endorsement in adult and adolescent MDD groups 
using odds ratios (OR).  Odds ratios greater than one denoted that a symptom was more 
common in the adolescent group. P values were FDR (false discovery rate) corrected for 
multiple comparisons.  Where evidence of differences in symptom frequency between 
adolescents and adults with MDD were found, sensitivity analyses were conducted to 
investigate the role of: age (comparing unaffected adolescents vs. unaffected adults), family 
history (comparing adults with vs. without a parent with MDD), gender (female participants 
only) and informant (adolescent self rated symptoms only).  For analyses that required 
comparison to unaffected participants, data from the first study time-point were used.  
Analyses utilising adolescent self-reported depressive symptoms were also run as a 
sensitivity check to examine any potential effect of informant.  Next, we examined the pattern 
of adult and adolescent depressive symptoms using latent class analysis (LCA) in MPlus 
(Muthén and Muthén, 2012).  Latent class analysis (LCA) is a “person-centred” approach 
that aims to group similar individuals into “classes” (categories). This thus allowed us to 
examine the patterns of symptom profiles for adults and adolescents.  In line with most 
recommendations we selected the optimal models on the basis of a number of factors 
including the meaning and interpretability of classes based on existing knowledge and 
theory; fit indices and the size of the smallest class – a minimum of around 5% of the sample 
(Jung & Wickrama, 2008).  To select the number of classes for the LCAs, we modelled k-
class solutions, modelling subsequent k+1 solutions until the optimum solution was reached.  
We used the sample size adjusted Bayesian information criterion (ssaBIC) to identify the 
best fitting models (Berlin et al., 2014).  In adolescents, the ssaBIC decreased across the 1-, 
2- and 3-class solutions (ssaBIC = 2627.18, 2490.08 and 2480.60 respectively), before 
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increasing for the 4-class solution (ssaBIC= 2487.94).  Consistent with this, the bootstrap 
likelihood ratio test (BLRT) showed that fit improved when including an additional class until 
the three class solution with no further improvement in fit when adding a fourth class (BLRT 
p = .1579).  Thus the 3-class solutions was selected. In adults, the ssaBIC decreased across 
the 1-, 2-, 3- and 4-class solutions (ssaBIC = 3425.30, 3016.33, 2997.11 and 2990.83 
respectively), before increasing for the 5-class solution (ssaBIC=2993.62). Consistent with 
this, the BLRT showed that fit improved when including an additional class until the four 
class solution with no further improvement in fit when adding a fifth class (BLRT p = 1).  
Thus the 4-class solutions was therefore selected. Both the adolescent and adult models 
had high entropy (0.96 and 0.83 respectively). Associations between the classes and MDD 
were investigated using the ‘best-guess’ class (Berlin et al., 2014; Muthén and Muthén, 
2012). 
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Results 
Depressive symptoms in adolescent and adult MDD 
109 adults (mean age= 41.5 years, range= 26-55) and 37 adolescents (mean age= 14.2 
years, range = 10-18) met DSM-IV diagnostic criteria for current MDD at least once during 
the study.  We compared the frequency of 10 DSM-IV depressive symptoms in the 
adolescents and adults where comparable data were available for both adolescent and adult 
samples (with appetite/weight change and sleep disturbance additionally disaggregated into 
increased or decreased appetite/weight and hypersomnia and insomnia) (Table 1).  As 
expected, all depressive symptoms were more common in those individuals with a diagnosis 
of MDD than those without.  The mean total number of symptoms was similar in adults and 
adolescents with MDD (7.1 vs 7.5) with both groups exhibiting severe MDD (WHO, 1992). 
The most common core DSM symptom exhibited by both adults and adolescents with MDD 
was depressed mood (Table 1).  The core symptom of loss of interest/anhedonia was more 
commonly observed in adult than adolescent MDD. In terms of the core symptom of irritable 
mood, no significant difference in the prevalence in adolescents with MDD (17%) and adults 
with MDD (30%) was observed.  In the adolescent MDD group, irritable mood was not 
present in any individual in the absence of depressed mood.   
 
In adolescents with MDD, the symptoms of loss of energy (97.2%), depressed mood 
(94.6%), insomnia (reduction in sleep by at least 2 hours per night; 86.5%) and 
worthlessness/guilt (81.1%) were very common.  In adults with MDD, the symptoms of 
depressed mood (98.2%), loss of interest/anhedonia (88.1%) and worthlessness/guilt 
(85.2%) predominated. While worthlessness/guilt was commonly endorsed in both adult and 
adolescents with MDD, several differences in symptom prevalence were observed.  Thus, as 
shown in Table 1, four symptoms were more common in adolescents with MDD: change in 
appetite, weight gain, weight loss, insomnia, loss of energy.  In contrast, two symptoms were 
more common in adults with MDD: loss of interest/anhedonia and loss of concentration.  
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Table 2 shows the results of sensitivity analyses to check whether observed differences 
between adolescent and adult MDD were attributable to age, family history, gender (females 
only).  The pattern of results largely remained the same.  The exceptions to this were that (a) 
loss of interest/anhedonia was in part more common in adult MDD due to age differences as 
this was also more common in unaffected adults compared to adolescents, (b) and that loss 
of energy may partly be more common in those at high familial risk as this was more 
common in adult cases with a family history of depression.  In summary, appetite and weight 
change and insomnia were more common in adolescents than adults with current MDD and 
this was robust to sensitivity checks.  Loss of energy was also more common in adolescent 
MDD although elevated familial risk for depression also contributed to this.  Loss of 
concentration was more common in adults and this finding was robust to sensitivity checks.  
 
Depressive symptom profiles in adolescents and adults 
Figure 1 illustrates the depressive symptom classes observed in adolescents and adults. In 
adolescents, three depressive symptom classes were identified: one characterised by low 
probability of endorsing depressive symptoms (87%), one with high probabilities of 
endorsing vegetative symptoms of depression (7%) and one with high probabilities of 
endorsing cognitive symptoms (6%).  The highest rates of MDD were seen in the vegetative 
symptoms class (56%) and these varied by class (χ2(2)=106.60, p<0.001; Figure 1).  In 
adults, four classes were identified: one characterised by low probability of endorsing 
depressive symptoms (46%; ‘low’), one with a high probability of endorsing several 
symptoms, particularly depressed mood, loss of interest and worthlessness (22%; ‘high’), 
one with a high probability of endorsing depressed mood and worthlessness (19%; ‘mood 
and negative cognitions’) and one with a high probability of endorsing anhedonia/loss of 
interest (14%; ‘anhedonia’) (Figure 1).  Again, rates of MDD varied by class for adults 
(χ2(3)=149.12, p<0.001), with highest rates in the ‘high’ class (98%), followed by the ‘mood 
and negative cognitions’ and ‘anhedonia’ classes (39% and 40% respectively) and no cases 
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in the low symptoms class.  Thus, the pattern of co-occurring symptoms associated with the 
highest probability of MDD in adolescents was one where vegetative symptoms 
predominated.  A profile where vegetative symptoms predominated was not observed in the 
adult sample. 
 
Discussion 
From a clinical perspective, it is useful to consider adult and adolescent depression as the 
same disorder.  Nevertheless, it is accepted that there are aetiological and treatment 
response differences between adolescent and adult depression.  Clinical descriptions of 
phenomenology in children and adolescents have also highlighted the potential importance 
of vegetative symptoms in early-onset forms of depression (Goodyer and Cooper, 1993; 
Nardi et al., 2013; Roberts et al., 1995; Ryan et al., 1987) but detailed systematic 
descriptions of these symptoms are generally lacking.  Moreover, the reliance of these 
descriptions on clinical samples of young people, collected at different times and from 
different places using different assessment procedures threatens the external validity of such 
findings given the ‘treatment gap’ for adolescent depression, the likelihood of cohort effects 
and idiosyncratic referral and assessment methods across different sites and settings 
(Roberts et al., 1995).  We attempted to address some of these limitations evident in the 
current literature by making use of a family cohort where parents and adolescent offspring 
were assessed repeatedly at the same time point using similar methods.   
 
In a family study which allows ‘matching by nature’ on a range of confounding factors and 
where similar assessment and diagnostic protocols for adults and adolescents were 
employed by the same research team, we found evidence that the presentation of MDD and 
depressive symptoms differs between adults and adolescents.  In a sample of adult and 
adolescent MDD cases well matched on their overall levels of severity, loss of energy (97%), 
sleep disturbance - specifically insomnia (87%) and appetite/weight disturbance (87%) were 
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more common in adolescent than adult MDD (figures were 71%; 63%; 59% for adult MDD).    
A similar pattern of findings also emerged for depressive symptoms using latent class 
analysis.  The symptom profile with a high probability of adolescent MDD involved appetite 
and weight change, insomnia and energy loss at high levels along with low mood.  
Conversely, the symptom profile with a high probability of adult MDD was characterised by 
high levels of all depressive symptoms except weight changes.  High levels of low mood and 
worthlessness were common to adult and adolescent MDD and depressive symptoms.  We 
observed that the vegetative symptoms of insomnia, appetite/weight change, loss of energy 
were more in adolescent depression and to some extent this distinguishes it from adult 
depression. 
 
It is recognised that there is substantial phenotypic heterogeneity in depression (Flint and 
Kendler, 2014).  The present findings also indicate phenotypic heterogeneity in the 
manifestations of depressive symptomatology in adults and adolescents using diagnostic 
and dimensional approaches to defining depression.  Loss of energy was observed in nearly 
all adolescents with MDD (97%) and at very high levels in the adolescent depression profile 
associated with the highest probability of MDD.  Thus, in this sample of depressed 
adolescents, loss of energy appeared to be a core depressive symptom.  Similar findings 
have been reported in other studies, for example Ryan and colleagues (1987) reported that 
fatigue was endorsed as a symptom in over 80% of a clinical sample of depressed children 
and adolescents. The importance of loss of energy as a ‘central’ depressive symptom which 
may trigger or cause other depressive symptoms has been reported in analyses of 
depressed adults (Fried et al., 2016).  The approach used by those authors involved testing 
whether particular symptoms are especially closely connected to other symptoms in a 
diagnostic symptom network.  It may be that ‘central’ depressive symptoms like energy loss 
are particularly important in initial onsets of the depressive syndrome - which often occur in 
adolescence or early adult life - because they ‘activate’ other symptoms.  Interestingly, 
sensitivity analyses suggested that loss of energy was also slightly more common in adults 
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with a history of depression in a parent (although not at the extremely high levels seen in 
adolescents) suggesting that a familial contribution may also contribute to this result.   
 
Insomnia was also a common feature of adolescent depression (87%).  Other studies have 
also reported that insomnia is present at high levels in youth depression – over 75% in a 
community sample of depressed adolescent girls (Goodyer and Cooper, 1993) and 88% with 
sleep disturbance in a US community sample (Roberts et al., 1995).  Nonetheless, the 
present results also showed that insomnia was unlikely to be associated with a high 
probability of MDD unless also accompanied by other depressive symptoms.  This is 
consistent with previous work using item response theory, showing that sleep disturbance 
emerged at low levels of depression severity (Cole et al., 2011).   
 
One final finding worthy of comment is that there was no evidence that irritability was more 
common in adolescent than adult depression despite the allowance of irritable mood as a 
core mood symptom for children and adolescents in DSM-IV and DSM 5 (APA, 2000, 2013).  
This finding is consistent with evidence that irritability does not appear to be a ‘hallmark’ 
mood criterion for depression in young people and that irritable mood is rare in youth 
depression without co-occurring depressed mood (Stringaris et al., 2013; Vidal-Ribas et al., 
2016).  It may instead be that irritability is an antecedent of depression in young people as 
has been suggested in longitudinal research (Vidal-Ribas et al., 2016).  Although we did not 
specifically examine that possibility in the present study, it has been reported in this sample 
previously (Rice et al., 2017).  
 
There are several potential reasons for the subtly different manifestations of depression that 
we observe in adults and adolescents including that depression is not age isomorphic and 
that there are differences in the symptoms manifested in initial onsets compared to 
recurrences.  Results may also have been influenced by treatment history.  Whatever the 
reason for these differing manifestations, one clinical implication is that not assessing 
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vegetative symptoms like insomnia, appetite change and energy loss in a young person may 
result in depression being missed.   
 
The present study has a number of strengths including the use of a community-based family 
study which controls for a wide range of potential confounds including those that are 
unmeasured (Sjolander and Zetterqvist, 2017).  This coupled with the use of similar 
standardized assessment and diagnostic protocols for adult and adolescent MDD and 
depressive symptoms additionally overcomes limitations of existing literature giving greater 
confidence in the age-related differences in symptomatology observed.  The use of a design 
that circumvents the need for service use in the adolescents is important given the 
substantial under-treatment of adolescent depression.  Nonetheless, the adults in the study 
were recruited via primary care so a level of treatment seeking was required for the adult 
sample but adults treated in primary care do not represent a highly selected group.  It should 
be acknowledged that the adult and adolescent samples were recruited in different ways 
raising the possibility that different sets of bias may operate in the referred adult and 
community based adolescent sample.  One potential limitation is the focus on a group of 
adolescents with a parent with a history of recurrent depression.  It could be argued that the 
focus on this high-risk group limits the generalizability of findings.  Nevertheless, we were 
able to test this in the sample of adults and found that results were mainly unchanged when 
comparing to adults with a history of depression in a parent.  Moreover, a history of 
depression in a parent is an extremely common risk factor for adolescent depression with 
estimates that 40-50% of depressed young people show familial history of MDD in a parent 
(Lieb et al., 2002).  Indeed, the rates of symptom types in the present adolescent MDD 
sample are extremely similar to those reported in the Oregon community-based adolescent 
MDD sample (Roberts et al., 1995) giving confidence that the present results are 
generalizable to adolescent MDD.  Another potential limitation is the inclusion of parent 
reports of adolescent depressive symptomatology on the grounds that parents’ evaluations 
of their children’s psychopathology are influenced by their own mental state, with currently 
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depressed parents reporting more problems in their children.  However, evidence illustrates 
that parents provide reliable and valid reports of their children’s motional state irrespective of 
their own depression with several studies suggesting that depressed parents are especially 
sensitive reporters of their children’s mental health (Lewis et al., 2012; Weissman et al., 
1987).  Whilst combining reports from parents and the young person themselves is the 
approach recommended by current UK clinical guidelines we did carry out a sensitivity check 
using adolescent self-rated symptoms only and found results replicated.  The prevalence of 
MDD was lower in the adolescent than adult sample.  This was unavoidable due to the 
method of recruitment and identification of participants in the study.  For the adolescent 
MDD group, the sample size was relatively small so results require replication.  However, 
results replicated for a continuous measure where sample size of those with depressive 
symptoms was equivalent in adolescents and adults.  Likewise, participants were mostly 
female although sensitivity checks found no evidence for substantial gender differences. 
While the methods of assessment and diagnoses were very similar, there were sometimes 
slight differences in the symptom criteria for the adult and adolescent psychiatric 
assessments e.g. ‘loss of concentration’ for adolescents was made up of the items 
‘inefficient thinking’ or ‘indecisiveness’ but ‘loss of concentration’ or ‘indecisiveness’ for 
adults.  Other considerations include that adolescent cases will have been more likely to be 
first onsets and that the use of a family design will have likely underestimated differences 
between adult and adolescent depression and so can be considered conservative.  
 
In summary, depression in adolescents differs in presentation to adult depression. Findings 
suggest that vegetative symptoms are a common presentation in adolescent depression. 
Given that early treatment remediates the long-term trajectory of adolescent depression, 
efforts to improve identification, access to brief therapeutic support and signposting for 
referral to specialist services remain warranted.  Results suggest the importance of 
assessing biological symptoms in young people and are consistent with the aetiology and 
treatment differences between depression in adults and adolescents.    
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Table 1. Comparing the prevalence of individual depressive symptoms in adolescent and 
adult MDD 
  Percentage of MDD cases 
with symptoms 
Association with adolescent 
versus adult MDD 
  Adults Adolescents OR (95% CI) FDR 
adjusted p 
C
or
e 
 Depressed mood  98.2 94.6 0.33 (0.04-2.41) 0.33 
Loss of interest/anhedonia 88.1 70.3 0.32 (0.13-0.80) 0.03 
Irritability 46.8 29.7 0.48 (0.22-1.07) 0.11 
V
eg
et
at
iv
e 
 
Change in appetite  56.0 78.4 2.85 (1.20-6.80) 0.03 
Weight gain 3.7 40.5 17.73 (5.37-58.56) 0.0001 
Weight loss 7.4 31.4 5.73 (2.08-15.79) 0.001 
Hypersomnia 22.9 22.9 1.00 (0.40-2.47) 0.99 
Insomnia  63.3 86.5 3.71 (1.34-10.29) 0.02 
Psychomotor retardation  30.3 35.1 1.25 (0.57-2.75) 0.63 
Loss of energy  70.6 97.2 14.55 (1.91-110.76) 0.003 
C
og
ni
tiv
e 
 Worthlessness/guilt 85.2 81.1 0.75 (0.28-1.98) 0.63 
Loss of concentration 74.3 38.9 0.22 (0.10-0.49) 0.0007 
Suicidality 65.4 50.0 0.53 (0.25-1.14) 0.14 
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Table 2. Sensitivity analyses 
OR (95% CI) Original finding  
(adolescent vs. adult MDD) 
Age  
(unaffected)  
Familial risk  
(adult MDD) 
Gender 
(females only) 
Informant 
(adolescent ratings 
only) 
Loss of interest/anhedonia 0.32 (0.13-0.80) 0.31 (0.14-0.67) 1.47 (0.38-5.72) 0.26 (0.10-0.73) .10 (.04, .25) 
Change in appetite  2.85 (1.20-6.80) 1.27 (0.82-1.96) 1.72 (0.73-4.05) 2.32 (0.91-5.92) .98 (.46, 2.10) 
Weight gain 17.73 (5.37-58.56) 3.10 (1.24-7.76) 0.95 (0.90-1.00) 20.56 (6.00-70.43) 4.33 (1.09, 17.16) 
Weight loss 5.73 (2.08-15.79) 1.40 (0.69-2.83) 0.89 (0.83-0.97) 5.33 (1.82-15.59) 4.33 (1.52, 12.31) 
Insomnia  3.71 (1.34-10.29) 1.47 (1.00-2.17) 0.81 (0.35-1.88) 5.61 (1.59-19.56) 1.74 (.74, 4.07) 
Loss of energy  14.55 (1.91-110.76) 2.76 (1.63-4.67) 2.98 (1.03-8.62) 11.04 (1.43-85.10) 3.33 (1.09, 10.17) 
Loss of concentration 0.22 (0.10-0.49) 1.33 (0.70-2.53) 1.77 (0.64-4.88) 0.19 (0.10-0.46) .13 (.06, .30) 
Sensitivity analyses conducted where evidence of a difference in prevalence between adolescent and adult MDD was found
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Figure 1 Latent Classes: Adolescents 
 
 
Latent Classes: Adults  
 
 
 
Footnote to Figure 1: The y axis represents the probability of a depressive symptom being 
endorsed.  For adolescents, the rates of MDD varied by class ( χ2(2)=106.60, p<0.001). The 
probability of MDD is highest in the vegetative class (54%); lowest in the low class (.01%) 
and intermediate in the cognitive class (29%).  For adults, the rates of MDD varied by class 
(χ2(3)=149.12, p<0.001). The probability of MDD is highest in the high class (97%), lowest in 
the low class (0%) and intermediate in the mood and negative cognitions (42%) and 
anhedonia (38%) classes. 
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